# US 2026/0226491 A1 · Modified tobacco plants with altered trichome characteristics and related methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0226491 A1
- Document ID: US20260226491A1
- Status: Published application
- Kind: A1
- Application number: 19/440,077
- Filed: 2026-01-05
- Published: 2026-08-06
- Earliest claimed: 2025-01-06
- Assignees: University of Virginia Patent Foundation
- Applicants: University of Virginia Patent Foundation
- Inventors: Michael Paul Timko; Hai Liu
- Web page: https://patentgrep.com/patent/US20260226491A1

## CPC

- A01H 6/823: {Nicotiana, e.g. tobacco}
- C12N 15/8263: {Ablation; Apoptosis}
- A01H 1/10: {Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits}
- A01H 5/12: Leaves
- C07K 14/415: from plants
- C12N 15/8242: {with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits}
- C12N 15/8218: {Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]}
- A01H: NEW PLANTS OR {NON-TRANSGENIC} PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present disclosure provides compositions and methods related to improving trichome characteristics in tobacco plants. Plants comprising non-natural mutations in genes involved in trichome growth are provided, as are products and cured tobacco material made from said plants. Plants comprising RNAi constructs against genes involved in trichome growth are provided, as are products and cured tobacco material made from said plants. Methods of making and using the provided plants are also provided.

## Claims

### Claim 1

A modified tobacco plant, or part thereof, comprising a non-natural mutation in an endogenous nucleic acid molecule, wherein the endogenous nucleic acid molecule encodes a HAIRPLUS1a (NtHAP1a) protein comprising the amino acid sequence of SEQ ID NO: 1, and wherein expression or activity of the NtHAP1a protein is reduced in the modified tobacco plant as compared to a control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 2

A modified tobacco plant, or part thereof, comprising a non-natural mutation in an endogenous nucleic acid molecule, wherein the endogenous nucleic acid molecule encodes a HAIRPLUS1b (NtHAP1b) protein comprising the amino acid sequence of SEQ ID NO: 2, and wherein expression or activity of the NtHAP1b protein is reduced in the modified tobacco plant as compared to a control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 3

A modified tobacco plant, or part thereof, comprising a non-natural mutation in an endogenous nucleic acid molecule, wherein the endogenous nucleic acid molecule encodes a HAIRPLUS2 (NtHAP2) protein comprising the amino acid sequence of SEQ ID NO: 3, and wherein expression or activity of the NtHAP2 protein is reduced in the modified tobacco plant as compared to a control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 4 (depends on 1)

The modified tobacco plant, or part thereof, of claim 1, wherein the endogenous nucleic acid molecule is a coding sequence comprising SEQ ID NO: 4.

### Claim 5 (depends on 2)

The modified tobacco plant, or part thereof, of claim 2, wherein the endogenous nucleic acid molecule is a coding sequence comprising SEQ ID NO: 5.

### Claim 6 (depends on 3)

The modified tobacco plant, or part thereof, of claim 3, wherein the endogenous nucleic acid molecule is a coding sequence comprising SEQ ID NO: 6.

### Claim 7 (depends on 1)

The modified tobacco plant, or part thereof, of claim 1, wherein the endogenous nucleic acid molecule is a genomic sequence comprising SEQ ID NO: 7.

### Claim 8 (depends on 2)

The modified tobacco plant, or part thereof, of claim 2, wherein the endogenous nucleic acid molecule is a genomic sequence comprising SEQ ID NO: 8.

### Claim 9 (depends on 3)

The modified tobacco plant, or part thereof, of claim 3, wherein the endogenous nucleic acid molecule is a genomic sequence comprising SEQ ID NO: 9.

### Claim 10 (depends on 1)

The modified tobacco plant of claim 1, wherein the modified tobacco plant further comprises a second non-natural mutation in an endogenous nucleic acid molecule encoding a HAIRPLUS1b (NtHAP1b) protein, wherein the endogenous NtHAP1b protein comprises the amino acid sequence of SEQ ID NO: 2, and wherein expression or activity of NtHAP1b is reduced in the modified tobacco plant as compared to a control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 11 (depends on 10)

The modified tobacco plant of claim 10, wherein the modified tobacco plant further comprises a third non-natural mutation in an endogenous nucleic acid molecule encoding a HAIRPLUS2 (NtHAP2) protein, wherein the endogenous NtHAP2 protein comprises the amino acid sequence of SEQ ID NO: 3, and wherein expression or activity of NtHAP2 is reduced in the modified tobacco plant as compared to a control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 12 (depends on 1)

The modified tobacco plant of claim 1, wherein the modified tobacco plant further comprises a second non-natural mutation in an endogenous nucleic acid molecule encoding a HAIRPLUS2 (NtHAP2) protein, wherein the endogenous NtHAP2 protein comprises the amino acid sequence of SEQ ID NO: 3, and wherein expression or activity of NtHAP2 is reduced in the modified tobacco plant as compared to a control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 13 (depends on 2)

The modified tobacco plant of claim 2, wherein the modified tobacco plant further comprises a second non-natural mutation in an endogenous nucleic acid molecule encoding a HAIRPLUS2 (NtHAP2) protein, wherein the endogenous NtHAP2 protein comprises the amino acid sequence of SEQ ID NO: 3, and wherein expression or activity of NtHAP2 is reduced in the modified tobacco plant as compared to a control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 14 (depends on 1)

The modified tobacco plant, or part thereof, of claim 1, wherein the non-natural mutation is a null mutation.

### Claim at position 15

-75. (canceled)

### Claim 76 (depends on 1)

The modified tobacco plant, or part thereof, of claim 1, wherein the modified tobacco plant is selected from the group consisting of a flue-cured tobacco plant, a bright tobacco plant, a Burley tobacco plant, a Virginia tobacco plant, a Maryland tobacco plant, a dark tobacco plant, a Galpão tobacco plant, an Oriental tobacco plant, and a Turkish tobacco plant.

### Claim 77 (depends on 1)

The modified tobacco plant, or part thereof, of claim 1, wherein the modified tobacco plant is selected from the group consisting of the tobacco plants listed in Table 2, Table 3, Table 4, Table 5, Table 6, Table 7, and Table 8.

### Claim at position 18

-79. (canceled)

### Claim 80 (depends on 1)

The modified tobacco plant, or part thereof, of claim 1, wherein the modified tobacco plant comprises an increased density of trichomes on at least one leaf as compared to the control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 81 (depends on 1)

The modified tobacco plant, or part thereof, of claim 1, wherein the modified tobacco plant comprises an increased number of trichomes on at least one leaf as compared to the control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 82 (depends on 1)

The modified tobacco plant, or part thereof, of claim 1, wherein the modified tobacco plant comprises an increased total number of trichomes as compared to the control tobacco plant lacking the non-natural mutation when grown under comparable conditions.

### Claim 83 (depends on 1)

A seed obtained from the modified tobacco plant, or part thereof, of any one of claim 1, wherein the seed comprises the non-natural mutation.

### Claim at position 23

-152. (canceled)
